PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18368132-2	2008	Standard chemoimmunotherapy consisting of dacarbazine (DTIC) given with IFN-alpha has had disappointing results.	Dacarbazine	55-59	interferon alpha	Mus musculus	72-81	
21389866-1	2011	Several large randomized clinical trials show that chemotherapy in combination with interferon-alpha (IFN-alpha) seems superior to single-agent chemotherapy, such as dacarbazine (DTIC) in melanoma, but the molecular mechanism of this better efficacy is unclear.	Dacarbazine	179-183	interferon alpha	Mus musculus	102-111	
21389866-4	2011	In B16 tumor-bearing mice, the addition of IFN-alpha to DTIC treatment significantly reduced tumor volume, compared with control or DTIC alone.	Dacarbazine	56-60	interferon alpha	Mus musculus	43-52	
21389866-4	2011	In B16 tumor-bearing mice, the addition of IFN-alpha to DTIC treatment significantly reduced tumor volume, compared with control or DTIC alone.	Dacarbazine	132-136	interferon alpha	Mus musculus	43-52